Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
CF Pharma- skilled & highly experienced European API producer based in Hungary.
About the Company : Established in 1996, CF Pharma Ltd. is a privately owned, independent developer & producer of APIs headquartered in Budapest, Hungary. It specializes in the development & manufactu...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Parenteral
Solubilizers
Global Sales Information
Market Place
APIs
Reply
28 Aug 2021
Reply
04 Aug 2021
Reply
12 Feb 2021
Reply
10 Dec 2019
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Physostigmine Salicylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Physostigmine Salicylate, including repackagers and relabelers. The FDA regulates Physostigmine Salicylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Physostigmine Salicylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Physostigmine Salicylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Physostigmine Salicylate supplier is an individual or a company that provides Physostigmine Salicylate active pharmaceutical ingredient (API) or Physostigmine Salicylate finished formulations upon request. The Physostigmine Salicylate suppliers may include Physostigmine Salicylate API manufacturers, exporters, distributors and traders.
click here to find a list of Physostigmine Salicylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Physostigmine Salicylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Physostigmine Salicylate active pharmaceutical ingredient (API) in detail. Different forms of Physostigmine Salicylate DMFs exist exist since differing nations have different regulations, such as Physostigmine Salicylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Physostigmine Salicylate DMF submitted to regulatory agencies in the US is known as a USDMF. Physostigmine Salicylate USDMF includes data on Physostigmine Salicylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Physostigmine Salicylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Physostigmine Salicylate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Physostigmine Salicylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Physostigmine Salicylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Physostigmine Salicylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Physostigmine Salicylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Physostigmine Salicylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Physostigmine Salicylate suppliers with NDC on PharmaCompass.
Physostigmine Salicylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Physostigmine Salicylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Physostigmine Salicylate GMP manufacturer or Physostigmine Salicylate GMP API supplier for your needs.
A Physostigmine Salicylate CoA (Certificate of Analysis) is a formal document that attests to Physostigmine Salicylate's compliance with Physostigmine Salicylate specifications and serves as a tool for batch-level quality control.
Physostigmine Salicylate CoA mostly includes findings from lab analyses of a specific batch. For each Physostigmine Salicylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Physostigmine Salicylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Physostigmine Salicylate EP), Physostigmine Salicylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Physostigmine Salicylate USP).
LOOKING FOR A SUPPLIER?
Comment (7)
